Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34
B Bonito1,2, D R P Sauter1,2, A Schwab3
1Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Universitetsparken 13, Copenhagen, Denmark.
Abstract:
In the recent decades, ion channels became the focus of cancer biologists, as many channels are overexpressed in tumour tissue and functionally they are linked to abnormal cell behaviour with processes including apoptosis, chemo- and radioresistance, proliferation and migration. KCa3.1 is a Ca2+-activated K+ channel that plays a central role in tumour progression in many cancer types. Therefore, the aim of the present study was to investigate KCa3.1 expression in pancreatic cancer cells and assess possible implications to disease progression. Using qPCR technique, we found abundant expression of KCa3.1 in pancreatic cancer cell lines. Patch clamp measurements on MiaPaCa-2 cells revealed a Ca2+-activated K+ current that matched biophysical characteristics as described for KCa3.1. Moreover, the current was sensitive to the commonly used channel modulators TRAM-34, clotrimazole and DC-EBIO, and it was abolished following transient gene knockdown of KCa3.1. We utilized both pharmacology and RNAi to assess a possible role of the channel in tumour cell behaviour. We found that the channel supported MiaPaCa-2 cell proliferation. Using RNAi protocols, we also identified KCa3.1 as important entity in cell invasion. However, TRAM-34 had unexpected stimulatory effects on cell migration and invasion estimated in various assays. Moreover, TRAM-34 increased intracellular Ca2+. In conclusion, we found prominent functional expression of KCa3.1 in pancreatic cancer cells. We provide evidence that the channel has a key role in cell proliferation and for the first time identify KCa3.1 as important entity in PDAC cell migration. We further reveal anomalous effects of TRAM-34.
Insights
Calcium-activated potassium channel 3.1 (KCa3.1) is functionally expressed in pancreatic cancer cells, driving proliferation and invasion. This study highlights KCa3.1
Area of Science:
- Oncology
- Molecular Biology
- Ion Channel Physiology
Background:
- Ion channels are increasingly recognized as key players in cancer biology.
- Aberrant ion channel function is linked to tumor progression, affecting apoptosis, drug resistance, proliferation, and migration.
- The calcium-activated potassium channel KCa3.1 is implicated in the progression of various cancer types.
Purpose of the Study:
- To investigate the expression and functional role of KCa3.1 in pancreatic cancer cells.
- To assess the implications of KCa3.1 activity on pancreatic cancer cell progression, including proliferation, migration, and invasion.
Main Methods:
- Quantitative PCR (qPCR) to assess KCa3.1 gene expression in pancreatic cancer cell lines.
- Patch clamp electrophysiology to characterize KCa3.1 channel activity in MiaPaCa-2 cells.
- Pharmacological inhibition and RNA interference (RNAi) to evaluate the functional impact of KCa3.1.
Main Results:
- KCa3.1 was abundantly expressed in pancreatic cancer cell lines.
- Functional KCa3.1 currents were confirmed in MiaPaCa-2 cells, sensitive to known modulators and gene knockdown.
- KCa3.1 knockdown inhibited MiaPaCa-2 cell proliferation and invasion.
- The KCa3.1 modulator TRAM-34 showed unexpected stimulatory effects on migration and invasion, alongside increased intracellular calcium.
Conclusions:
- Pancreatic cancer cells exhibit prominent functional expression of KCa3.1.
- KCa3.1 plays a crucial role in pancreatic cancer cell proliferation and invasion.
- This study is the first to identify KCa3.1's role in pancreatic ductal adenocarcinoma (PDAC) cell migration.
- Anomalous effects of the KCa3.1 modulator TRAM-34 warrant further investigation.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

